AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 17- Open
- $250.60
- 52-wk high
- $267.47
- High
- $250.61
- 52-wk low
- $189.40
- Low
- $247.68
- Prev close
- $250.82
Smart money
Earnings
Reported Jul 31, 2026
Earnings landed in line with what analysts expected.
Financials
Sep 2025 to Jun 2026
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| RevenueTotal revenue | $15.78B | $16.62B | $15.00B | $16.99B |
| Cost of what it soldCost of revenue | $5.30B | $4.55B | $4.22B | $4.29B |
| Gross profit | $10.47B | $12.07B | $10.78B | $12.70B |
| What it spent | ||||
| Research and development | $2.32B | $2.58B | $2.47B | $2.34B |
| Sales and adminSelling, general and administrative | $3.57B | $3.90B | $3.58B | $3.63B |
| Other operating costsOperating costs not itemised in the filing's summary | $2.68B | -$217.0M | — | $291.0M |
| Total operating expenses | $8.57B | $6.26B | $6.05B | $6.27B |
| What was left | ||||
| Operating profitOperating income | $1.90B | $5.81B | $4.73B | $6.43B |
| Interest on debtInterest expense | $739.0M | $714.0M | $717.0M | $746.0M |
| Profit before tax | $714.0M | $2.67B | $1.04B | $4.28B |
| TaxIncome tax expense | $526.0M | $853.0M | $342.0M | $662.0M |
| Net profitNet income | $186.0M | $1.82B | $699.0M | $3.61B |
| EBITDAEarnings before interest, tax, depreciation, amortisation | $3.52B | $5.37B | $3.69B | $8.66B |
Technicals
Technicals
Price structure
This stock's price action is mixed.
Trend
Mixed
45 / 100
RSI 14
41balanced
20D volatility
21%annualized
52-week range
$249.46$189.40$267.47
20D support
News
News
What the news says
50 articles · 7 days
Coverage is bullish
33 bullish · 16 neutral · 1 bearish
Tone of tracked coverage
Should Income Investors Look At Amgen Inc. (NASDAQ:AMGN) Before Its Ex-Dividend?
NeutralAug 16Will Gilead’s AI-Driven ADC Research with Nucleai Refine Its Oncology Strategy and Valuation Story (GILD)?
NeutralAug 16Mirae Asset Global Investments Co. Ltd. Has $124.56 Million Stock Holdings in AbbVie Inc. $ABBV
Leans bullish
